Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00733707 · ClinicalTrials.gov registry record · NA

Improving Adherence With Oral Contraceptives Using Daily Text Messaging Reminders

A NA study of Oral Contraceptive Pill Adherence, sponsored by Planned Parenthood League of Massachusetts.

Completed
Registry status
NA
Development phase
82
Enrollment target
1
Study location

NCT00733707 is a NA study of Oral Contraceptive Pill Adherence that has completed, run by Planned Parenthood League of Massachusetts. The registered enrollment target is 82 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00733707, a NA study of Oral Contraceptive Pill Adherence, has completed, sponsored by Planned Parenthood League of Massachusetts.

COMPLETED
Registry status
NA
Development phase
82 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether there is increased oral contraceptive pill (OCP) adherence in women receiving daily text messaging reminders to take their OCP, compared to women who do not receive reminders. The investigators hypothesize that women who receive daily text messaging reminders to take their OCP will have increased pill adherence compared to women who do not receive reminders. The investigators also hope to determine whether there is a difference in OCP adherence as measured by electronic monitoring device and wireless real-time data collection versus traditional patient pill diaries. The investigators hypothesize that electronic monitoring device and wireless real-time data collection will demonstrate lower adherence compared to traditional patient pill diaries.

Interventions

  • BEHAVIORAL Text messaging reminders

Study Locations (1)

Massachusetts

  • Planned Parenthood League of Massachusetts - Boston

Trial Details

FieldValue
Enrollment Target 82 participants
Start Date 2008-08
Est. Completion 2009-06
Phase NA

What the Registry Record Tells You About NCT00733707

The ClinicalTrials.gov registry entry for NCT00733707 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Planned Parenthood League of Massachusetts, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Oral Contraceptive Pill Adherence appearing as the primary indexed condition, and to 1 intervention - of which Text messaging reminders is the first listed.

NCT00733707 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00733707 about?

NCT00733707 is a clinical study titled "Improving Adherence With Oral Contraceptives Using Daily Text Messaging Reminders". The purpose of this study is to determine whether there is increased oral contraceptive pill (OCP) adherence in women receiving daily text messaging reminders to take their OCP, compared to women who do not receive reminders. The investigators hypothesize that women who receive daily text messaging ...

What is the current status of trial NCT00733707?

This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2008-08. Estimated completion is 2009-06.

What conditions does trial NCT00733707 study?

This clinical trial studies the following conditions: Oral Contraceptive Pill Adherence.

What interventions are being tested in trial NCT00733707?

The interventions under investigation include: Text messaging reminders (BEHAVIORAL).

Who is sponsoring clinical trial NCT00733707?

This trial is sponsored by Planned Parenthood League of Massachusetts, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00733707 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.